Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Pilot Study of the Efficacy, Safety and Tolerability of Bictegravir-Based HIV ART Same-Day Treatment Evaluations (B-HASTE)

NCT04249037 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04249037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04249037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Pilot Study of the Efficacy, Safety and Tolerability of Bictegravir-Based HIV ART Same-Day Treatment Evaluations (B-HASTE)
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Terminated
Start date
December 15, 2020
Completion date
July 1, 2023
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv/aids